BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24168180)

  • 1. Downregulation of PTEN expression in psoriatic lesions.
    Li Y; Man X; You L; Xiang Q; Li H; Xu B; Chen Z; Zhang X; Lian S
    Int J Dermatol; 2014 Jul; 53(7):855-60. PubMed ID: 24168180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease.
    Long SH; He Y; Chen MH; Cao K; Chen YJ; Chen BL; Mao R; Zhang SH; Zhu ZH; Zeng ZR; Hu PJ
    J Dig Dis; 2013 Dec; 14(12):662-9. PubMed ID: 23962154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway.
    Wang R; Wang FF; Cao HW; Yang JY
    Life Sci; 2019 Aug; 230():28-34. PubMed ID: 31108094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Down-regulation of PTEN expression in kidney and its role in development of diabetic nephropathy in rats].
    Wang YY; Liu RX; Guo B; Xiao Y; Shi MJ; Pi MJ; Wen QY; Zhang GZ
    Sheng Li Xue Bao; 2011 Aug; 63(4):325-32. PubMed ID: 21861051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells.
    Zhu G; Chai J; Ma L; Duan H; Zhang H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):526-31. PubMed ID: 23524257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-559 and MTDH as possible diagnostic markers of psoriasis: Role of PTEN/AKT/FOXO pathway in disease pathogenesis.
    Aldabbas R; Shaker OG; Ismail MF; Fathy N
    Mol Cell Biochem; 2023 Jul; 478(7):1427-1438. PubMed ID: 36348199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells].
    Zhai YN; Xu LL; Shen Y; Xia H; Shen YF
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):682-5. PubMed ID: 21092549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
    Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
    Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
    Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN.
    Iwase A; Goto M; Harata T; Takigawa S; Nakahara T; Suzuki K; Manabe S; Kikkawa F
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2184-91. PubMed ID: 19318457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue.
    Ling HY; Hu B; Hu XB; Zhong J; Feng SD; Qin L; Liu G; Wen GB; Liao DF
    Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):553-9. PubMed ID: 22956257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?
    Colakoglu T; Yildirim S; Kayaselcuk F; Nursal TZ; Ezer A; Noyan T; Karakayali H; Haberal M
    Am J Surg; 2008 Jun; 195(6):719-25. PubMed ID: 18440486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects.
    Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
    Biol Psychiatry; 2010 Jun; 67(11):1017-25. PubMed ID: 20163786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
    Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
    Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4.
    Ahn Y; Hwang CY; Lee SR; Kwon KS; Lee C
    Biochem J; 2008 Jun; 412(2):331-8. PubMed ID: 18307411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.